Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Washer 

Boston Scientific diskutieren

Boston Scientific

WKN: 884113 / Symbol: BSX / Name: Boston Scient / Aktie / Ausrüstung & Versorgung / Large Cap /

66,00 €
3,13 %

Boston Scientific (NYSE:BSX) had its "buy" rating reaffirmed by analysts at TD Cowen.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -15,17 %
Kursziel 105,03
Veränderung
Endet am 03.02.27

Boston Scientific (NYSE:BSX) had its price target lowered by analysts at Barclays PLC from $136.00 to $124.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,48 %
Kursziel 100,02
Veränderung
Endet am 05.02.27

Boston Scientific (NYSE:BSX) had its price target lowered by analysts at Morgan Stanley from $130.00 to $118.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,48 %
Kursziel 82,22
Veränderung
Endet am 05.02.27

Boston Scientific (NYSE:BSX) had its price target lowered by analysts at Needham & Company LLC from $121.00 to $97.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,48 %
Kursziel 80,52
Veränderung
Endet am 05.02.27

Boston Scientific (NYSE:BSX) had its price target lowered by analysts at Truist Financial Corporation from $120.00 to $95.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,48 %
Kursziel 79,67
Veränderung
Endet am 05.02.27

Boston Scientific (NYSE:BSX) had its price target lowered by analysts at Wells Fargo & Company from $125.00 to $94.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -0,30 %
Kursziel 81,37
Veränderung
Endet am 05.02.27

Boston Scientific (NYSE:BSX) had its price target lowered by analysts at Evercore ISI from $112.00 to $96.00. They now have an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,54 %
Kursziel 97,47
Veränderung
Endet am 05.02.27

Boston Scientific (NYSE:BSX) had its price target lowered by analysts at Royal Bank Of Canada from $130.00 to $115.00. They now have an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -0,60 %
Kursziel 84,76
Veränderung
Endet am 05.02.27

Boston Scientific (NYSE:BSX) had its price target lowered by analysts at JPMorgan Chase & Co. from $135.00 to $100.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat